Safarchi Azadeh, Al-Qadami Ghanyah, Tran Cuong D, Conlon Michael
Microbiome for One Systems Health FSP, CSIRO, Westmead, NSW, Australia.
Health and Biosecurity Research Unit, CSIRO, Adelaide, SA, Australia.
Front Microbiol. 2025 Mar 4;16:1559521. doi: 10.3389/fmicb.2025.1559521. eCollection 2025.
The healthy gut microbiome is important in maintaining health and preventing various chronic and metabolic diseases through interactions with the host via different gut-organ axes, such as the gut-brain, gut-liver, gut-immune, and gut-lung axes. The human gut microbiome is relatively stable, yet can be influenced by numerous factors, such as diet, infections, chronic diseases, and medications which may disrupt its composition and function. Therefore, microbial resilience is suggested as one of the key characteristics of a healthy gut microbiome in humans. However, our understanding of its definition and indicators remains unclear due to insufficient experimental data. Here, we review the impact of key drivers including intrinsic and extrinsic factors such as diet and antibiotics on the human gut microbiome. Additionally, we discuss the concept of a resilient gut microbiome and highlight potential biomarkers including diversity indices and some bacterial taxa as recovery-associated bacteria, resistance genes, antimicrobial peptides, and functional flexibility. These biomarkers can facilitate the identification and prediction of healthy and resilient microbiomes, particularly in precision medicine, through diagnostic tools or machine learning approaches especially after antimicrobial medications that may cause stable dysbiosis. Furthermore, we review current nutrition intervention strategies to maximize microbial resilience, the challenges in investigating microbiome resilience, and future directions in this field of research.
健康的肠道微生物群对于维持健康以及通过不同的肠道-器官轴(如肠-脑轴、肠-肝轴、肠-免疫轴和肠-肺轴)与宿主相互作用来预防各种慢性和代谢性疾病至关重要。人类肠道微生物群相对稳定,但会受到多种因素的影响,如饮食、感染、慢性疾病和药物,这些因素可能会破坏其组成和功能。因此,微生物弹性被认为是人类健康肠道微生物群的关键特征之一。然而,由于实验数据不足,我们对其定义和指标的理解仍不明确。在此,我们综述了包括饮食和抗生素等内在和外在因素在内的关键驱动因素对人类肠道微生物群的影响。此外,我们讨论了有弹性的肠道微生物群的概念,并强调了潜在的生物标志物,包括多样性指数和一些作为恢复相关细菌的细菌分类群、抗性基因、抗菌肽和功能灵活性。这些生物标志物可以通过诊断工具或机器学习方法,特别是在可能导致稳定生态失调的抗菌药物治疗后,促进对健康和有弹性的微生物群的识别和预测,尤其是在精准医学中。此外,我们综述了当前最大化微生物弹性的营养干预策略、研究微生物群弹性的挑战以及该研究领域的未来方向。
Front Microbiol. 2020-9-15
Naunyn Schmiedebergs Arch Pharmacol. 2025-4-9
Therap Adv Gastroenterol. 2022-11-18
Crit Rev Toxicol. 2024-9
Gut. 2024-10-7
Heliyon. 2024-8-12
FEMS Microbiol Rev. 2024-3-1
Sci Transl Med. 2024-1-17
Microbiome Res Rep. 2023-5-6
Microbiome Res Rep. 2023-1-17
Front Microbiol. 2023-11-3